Table 2 Patient characteristics and treatment duration

Age (years)

  < 1

104 (56)

15

11–23.5

0.31^b

  1–4

41 (22)

17

12–31

  5–11

21 (11)

15

11–20

  ≥ 12

21 (11)

15

10–23

Severity of illness

  PRISM-IV^c score

0.2

    < 8

93 (50)

15

11–23

    ≥ 8

94 (50)

16

12–30

Comorbidities

  Cardiovascular

0.97

    Yes

71 (38)

16

11–25

    No

116 (62)

15

11–25

  Respiratory

0.74

    Yes

42 (23)

15.5

12–20

    No

145 (78)

15

11–27

  Neurological

0.94

    Yes

24 (13)

16

13.5–19.5

    No

163 (87)

15

11–26

  Immunosuppressed

0.48

    Yes

43 (23)

15

10–23

    No

144 (77)

15

11–26